Clinical trial
Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting…
NCT00199745 · Oslo University Hospital, Other · Completed
Key facts
| NCT number | NCT00199745 |
|---|---|
| Title | Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity |
| Official title | Investigations on Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity |
| Lead sponsor | Oslo University Hospital, Other |
| Collaborators | University of Oslo School of Pharmacy |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Muscular Diseases |
| Intervention type | Drug |
| Interventions | atorvastatin |
| Enrollment | 53 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | May 10, 2012 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: